| Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males. (NCT00468806) | GlaxoSmithKline | 2007-04-01 |
| Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs (NCT00652288) | Yale University | 2007-04-01 |
| Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk Neuroblastoma (NCT00471679) | Memorial Sloan Kettering Cancer Center | 2007-04-01 |
| Study of the Mechanisms of Asthma (NCT00595153) | University of California, San Francisco | 2007-04-01 |
| Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation (NCT00374933) | Abramson Cancer Center at Penn Medicine | 2007-04-01 |
| Study of XL418 in Adults With Solid Tumors (NCT00460278) | Exelixis | 2007-04-01 |
| AV650 Drug-Drug Interaction Study (NCT00456560) | Avigen | 2007-04-01 |
| Endoscopic Treatment During Endodontic Procedures (NCT01192607) | Barzilai Medical Center | 2007-04-01 |
| A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers (NCT00504816) | GlaxoSmithKline | 2007-04-01 |
| A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine (NCT00741234) | S*BIO | 2007-04-01 |
| Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers (NCT00546273) | Germans Trias i Pujol Hospital | 2007-04-01 |
| Randomized Trial of Psychotherapy for Persistently Depressed Primary Care Patients (NCT00541957) | Butler Hospital | 2007-04-01 |
| A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women (NCT00540878) | GlaxoSmithKline | 2007-04-01 |
| Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma (NCT00458952) | Molecular Insight Pharmaceuticals, Inc. | 2007-04-01 |
| A Study of ARRY-520 in Patients With Advanced Cancer (NCT00462358) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2007-04-01 |
| Prevention of Self-care Deterioration in Early Adolescents With Diabetes (NCT00890331) | Virginia Commonwealth University | 2007-04-01 |
| Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT01561014) | Wake Forest University Health Sciences | 2007-04-01 |
| A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso (NCT00452088) | African Malaria Network Trust | 2007-04-01 |
| Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults (NCT00428337) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-04-01 |
| Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD) (NCT00967096) | Emory University | 2007-04-01 |
| Transcranial Magnetic Stimulation for Bipolar Depression (NCT00470639) | The University of New South Wales | 2007-04-01 |
| Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients (NCT01290965) | Scynexis, Inc. | 2007-04-01 |
| Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958 (NCT00311714) | Biota Scientific Management Pty Ltd | 2007-04-01 |
| Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India (NCT00486382) | Access to Advanced Health Institute (AAHI) | 2007-04-01 |
| Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia (NCT00101153) | University Health Network, Toronto | 2007-04-01 |
| Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. (NCT00565227) | University of Michigan Rogel Cancer Center | 2007-04-01 |
| Clinical Trial of Trametes Versicolor in Women With Breast Cancer (NCT00680667) | Masonic Cancer Center, University of Minnesota | 2007-04-01 |
| A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan (NCT00421811) | Adherex Technologies, Inc. | 2007-04-01 |
| Safety Study of SRX251 Capsules in Healthy Female Volunteers (NCT00461370) | Azevan Pharmaceuticals | 2007-04-01 |
| Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer (NCT00473954) | EGEN, Inc. | 2007-04-01 |
| Safety, Tolerability and Pharmacokinetics of BI 44370 TA Oral Drinking Solution in Healthy Male Volunteers (NCT02215018) | Boehringer Ingelheim | 2007-04-01 |
| Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia. (NCT00466895) | Leslie Andritsos | 2007-04-01 |
| Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation (NCT00471133) | Ichor Medical Systems Incorporated | 2007-04-01 |
| Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 (NCT00471367) | AstraZeneca | 2007-04-01 |
| Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS) (NCT00580593) | University of Michigan | 2007-04-01 |
| Indomethacin Versus Nifedipine for Preterm Labor Tocolysis (NCT00486824) | Stanford University | 2007-04-01 |
| Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients (NCT01539915) | Novartis Pharmaceuticals | 2007-04-01 |
| Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity (NCT00495053) | Urovant Sciences GmbH | 2007-04-01 |
| Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects (NCT00621101) | University Medicine Greifswald | 2007-04-01 |
| Concentration of Itraconazole Solution in Nasal Secretions (NCT00588016) | Mayo Clinic | 2007-04-01 |
| Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease (NCT00462189) | Cambridge Antibody Technology | 2007-04-01 |
| Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis (NCT00446784) | Pfizer | 2007-04-01 |
| Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers (NCT00864604) | Actavis Inc. | 2007-04-01 |
| Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease (NCT00465959) | Endo USA Inc., a Keenova Therapeutics Company | 2007-04-01 |
| A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women (NCT00499928) | GlaxoSmithKline | 2007-04-01 |
| Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms (NCT00479778) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-04-01 |
| Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer (NCT00872625) | Centre Antoine Lacassagne | 2007-04-01 |
| GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00607724) | Genentech, Inc. | 2007-04-01 |
| Effect of a Proton Pump Inhibitor on Gleevec® in Healthy Volunteers (NCT00446004) | University of Pittsburgh | 2007-04-01 |
| Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia (NCT00470197) | National Cancer Institute (NCI) | 2007-04-01 |
| Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression (NCT00444236) | University of Utah | 2007-04-01 |
| Double Blind Placebo Controlled Bellis Perenis and Arnica Montana as a Drug for PPH (NCT00405626) | Hadassah Medical Organization | 2007-04-01 |
| Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg (NCT00649168) | Mylan Pharmaceuticals Inc | 2007-04-01 |
| Improved Delivery of Cardiovascular Care Through Outreach Facilitation (NCT00574808) | C. T. Lamont Primary Care Research Centre | 2007-04-01 |
| Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects (NCT00456417) | Institute for Neurodegenerative Disorders | 2007-04-01 |
| Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients (NCT00466466) | Novartis Pharmaceuticals | 2007-04-01 |
| Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures (NCT00437281) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-04-01 |
| Oral Misoprostol for Labor Augmentation: A Pilot Study (NCT00906126) | University of Texas Southwestern Medical Center | 2007-04-01 |
| The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes (NCT00247026) | Hadassah Medical Organization | 2007-04-01 |
| An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 (NCT01664728) | Janssen Research & Development, LLC | 2007-04-01 |
| A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency (NCT00455260) | Teva Neuroscience, Inc. | 2007-04-01 |
| Comparison Of Two Tablet Formulations Of SB-568859 (NCT00470145) | GlaxoSmithKline | 2007-04-01 |
| Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma (NCT00472017) | St. Jude Children's Research Hospital | 2007-04-01 |
| A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED) (NCT00679055) | Merck Sharp & Dohme LLC | 2007-03-31 |
| Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation (NCT00457067) | National Eye Institute (NEI) | 2007-03-27 |
| Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation (NCT00457145) | National Eye Institute (NEI) | 2007-03-27 |
| A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder (NCT00555139) | GlaxoSmithKline | 2007-03-27 |
| Model System for Transient Forearm Blood Vessel Dysfunction (NCT00453531) | National Heart, Lung, and Blood Institute (NHLBI) | 2007-03-26 |
| A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites. (NCT00468897) | GlaxoSmithKline | 2007-03-21 |
| Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 (NCT00466531) | Memorial Sloan Kettering Cancer Center | 2007-03-21 |
| Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme (NCT00387400) | NCIC Clinical Trials Group | 2007-03-20 |
| A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809 (NCT00437840) | GlaxoSmithKline | 2007-03-20 |
| Imaging of Cannabinoid Receptors Using New Radioactive Tracer (NCT00450021) | National Institute of Mental Health (NIMH) | 2007-03-19 |
| Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00453154) | National Cancer Institute (NCI) | 2007-03-15 |
| A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease (NCT00459550) | GlaxoSmithKline | 2007-03-12 |
| A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers. (NCT00453687) | GlaxoSmithKline | 2007-03-09 |
| AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies (NCT00463814) | AstraZeneca | 2007-03-08 |
| A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia (NCT00587457) | MedImmune LLC | 2007-03-07 |
| Oral Contraceptive Interaction Study for GW273225 (NCT00483535) | GlaxoSmithKline | 2007-03-07 |
| Closure of Skin Incision Using CO2 Laser (NCT02149979) | Avraham Katzir | 2007-03-01 |
| Effect of Ranibizumab on Malignant Conjunctival Neoplasia (NCT00456495) | The New York Eye Cancer Center | 2007-03-01 |
| BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer (NCT00447122) | Brown University | 2007-03-01 |
| Vascular Sealant Study (NCT00618358) | Georgetown University | 2007-03-01 |
| Study Evaluating Safety and Tolerability of Inotuzumab Ozogamicin (CMC-544) in Japanese Patients With B-cell Non-Hodgkin's Lymphoma (NHL) (NCT00717925) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-03-01 |
| The Effect of Plasma Osmolality on Brain Glutamate (NCT00611741) | Yale University | 2007-03-01 |
| A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer (NCT00437502) | Michael Morse, MD | 2007-03-01 |
| Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema (NCT00440609) | Philip J. ferrone, M.D. | 2007-03-01 |
| Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma (NCT01266707) | Fukushima Medical University | 2007-03-01 |
| A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma (NCT00417677) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-03-01 |
| GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia (NCT00459212) | National Cancer Institute (NCI) | 2007-03-01 |
| Dose Proportionality Study Comparing Amaryl-M 1/500 mg and Amaryl-M 2/500 mg (NCT00934817) | Handok Inc. | 2007-03-01 |
| Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg (NCT00648882) | Mylan Pharmaceuticals Inc | 2007-03-01 |
| Study of NK012 in Patients With Refractory Solid Tumors (NCT00542958) | Nippon Kayaku Co., Ltd. | 2007-03-01 |
| Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors (NCT00462553) | National Cancer Institute (NCI) | 2007-03-01 |
| Logan Basic During Pregnancy on Labor and Childbirth (NCT00740350) | Logan College of Chiropractic | 2007-03-01 |
| Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease (NCT00457860) | Cambridge Antibody Technology | 2007-03-01 |
| Drug-Drug Interaction Study of Qualaquin and Midazolam (NCT00785486) | Mutual Pharmaceutical Company, Inc. | 2007-03-01 |
| Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas (NCT00457574) | Gemin X | 2007-03-01 |
| Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times Daily (NCT02549469) | Bayer | 2007-03-01 |
| Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers (NCT00483990) | Plethora Solutions Ltd | 2007-03-01 |